Bandingkan Harga & Kinerja Maharaksa Biru Energi Tbk. (OASA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Maharaksa Biru Energi Tbk. dan Organon Pharma Indonesia Tbk.: Maharaksa Biru Energi Tbk. diperdagangkan di Rp306 (kapitalisasi pasar 1,98 T, volume 24 jam 18,6 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Maharaksa Biru Energi Tbk. jauh lebih besar — sekitar 19× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| OASA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,98 T | 104,4 M |
Volume | 18,6 jt | — |
Lot | 186,03 rb | — |
Perputaran | 5,71 M | — |
Harga Rata-rata | 306,76 | — |
Nilai Transaksi | 5,71 M | — |
Harga Ekuilibrium Indikatif | 306 | — |
Volume Ekuilibrium Indikatif | 8,82 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Maharaksa Biru Energi Tbk.
PT. Protech Mitra Perkasa Tbk (the Company) was established on April 20, 2006 based on the Notarial Deed No. 72 of Mellyani Noor Shandra S.H. The Company is starting as general trading and contracting company, the company continue to grow and build a solid reputation within the telecommucication industry. Complementing its trade and construction business, in 2013, the Company extends its services by providing managed services for Telco Towers through its full subsidiary, Telesys Indonesia.
Selengkapnya di halaman OASA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
